American Cancer Society.Cancer Facts & Figures—1998. Atlanta: American Cancer Society, 1998.
2.
Gloeckler-RiesLAHankeyBFHarrasA. Cancer incidence, mortality, and patient survival in the United States. In: SchottenfeldDFraumeniJFJr., editors. Cancer Epidemiology and Prevention. New York: Oxford University Press, 1996:173–4.
3.
LallemandRCVakilPAPearsonP. Screening for asymptomatic bowel cancer in general practice. BMJ1984;288:31–3.
4.
FarrandsPAGriffithsRLBrittonDC. The Frome Experiment—value of screening for colorectal cancer. Lancet1981;1:1231–2.
5.
MillonRHowarthJTurnbergE. Faecal occult blood testing for colorectal cancer in general practice. Practitioner1982;226:659–63.
6.
BoothroydW. Prevention and early detection of cancer in the workplace. Occup Health1990;42:178–9.
7.
St. JohnDJBMcDermottFTHopperJL. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med1993; 118:785–90.
8.
Fortune 1 thousand ranked within industries.Fortune. April 28, 1997: F44–F66.
9.
HartARBaroneTLWicksACB. National industry's interest in colorectal cancer screening programmes. J R Soc Med1994;87:651–4.
10.
HartARWicksACBMayberryJF. A survey of industries and colorectal cancer screening of employees in the East Midlands of England. J R Soc Med1993;86:571–2.
